טוען...
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
Endometrial cancer (EC) is the most common gynecologic malignancy and still remains clinically challenging. We aimed to explore the potential biomarkers of EC and provide a theoretical basis for early screening and targeted therapy. The available transcriptome data from The Cancer Genome Atlas (TCGA...
שמור ב:
| הוצא לאור ב: | Eur J Histochem |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PAGEPress Publications, Pavia, Italy
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054569/ https://ncbi.nlm.nih.gov/pubmed/33782625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/ejh.2021.3226 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|